A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety (Q42678576)

4 November 2017

title

A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety (English)

1 reference

4 November 2017

Wallis CJ

1

1 reference

4 November 2017

Lal H

series ordinal

2

1 reference

4 November 2017

publication date

1 April 1998

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

4 November 2017

published in

1 reference

4 November 2017

volume

22

1 reference

4 November 2017

issue

3

1 reference

4 November 2017

page(s)

547-565

1 reference

A comparison of feeding and locomotion responses to serotonin agonists in three rat strains.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Withdrawal from morphine generalizes to a pentylenetetrazol stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Opioid modulation of the discriminative stimulus produced by pentylenetetrazol

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

A TRS-80-based system for the control of behavioral experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Inter-animal olfactory cues in operant drug discrimination procedures in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

5-HT1 and 5-HT2 binding characteristics of some quipazine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Role of 5-HT in defensive behavior and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Anxiety-like subjective effect of ethanol antagonist RO 15-4513 demonstrated in pentylenetetrazol discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Behavioral analogues of anxiety animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: Reversal by buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

1 reference

7 January 2021

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Sensitization to 5-HT1C receptor agonist in rats observed following withdrawal from chronic ethanol.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Animal models of anxiety and the development of novel anxiolytic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900024-4

7 January 2021

10.1016/S0278-5846(98)00024-4

Identifiers

DOI

1 reference

4 November 2017

1 reference